SCHEMBL150409

SCHEMBL150409

CC1[CH]CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL864234 1.00
SCHEMBL15121454 1.00
SCHEMBL2212661 0.97
SCHEMBL6755873 0.97
SCHEMBL42053 0.97
Cyclopentane SCHEMBL28236026 0.91
SCHEMBL38358 0.88
SCHEMBL3362869 0.88
Potassium Ion SCHEMBL28692656 0.85
SCHEMBL28237172 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1917 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3662751-B1 PYRAZOLO[4,3-C]QUINOLINE DERIVATIVES FOR INHIBITION OF B-GLUCURONIDASE UNIV KAOHSIUNG MEDICAL (TW) 2021-10-13 EP claimed
CN-118344338-A Substituted 4-aminoisoindoline-1, 3-dione compounds and their use for the treatment of lymphomas 细胞基因公司 2024-07-16 CN disclosed
CN-118317943-A Synthesis method of chiral 3, 5-disubstituted morpholine compound and useful intermediate thereof 百济神州有限公司 2024-07-09 CN disclosed
CN-118290488-A Pt complex and application thereof in organic light-emitting device 浙江华显光电科技有限公司 2024-07-05 CN disclosed
WO-2024140935-A1 B7H3 ANTIBODY DRUG CONJUGATES BEIGENE, LTD. (KY) 2024-07-04 WO disclosed
WO-2024140678-A1 A KETAL PROTECTED INTERMEDIATE FOR SONROTOCLAX AND PREPARATION METHOD THEREOF BEIGENE (SUZHOU) CO., LTD. (CN) 2024-07-04 WO disclosed
US-20240217955-A1 SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2024-07-04 US disclosed
WO-2024140690-A1 INTERMEDIATES OF SONROTOCLAX AND THE METHOD OF PREPARING THE SAME BEIGENE (SUZHOU) CO., LTD. (CN) 2024-07-04 WO disclosed
US-12023341-B2 Platinum-acridine compounds and methods of treating cancers WAKE FOREST UNIVERSITY (US) 2024-07-02 US disclosed
CN-118284670-A Colored resin composition, colored resin composition set, and color filter 三菱化学株式会社 2024-07-02 CN disclosed
WO-1992017185-A1 TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES UNIVERSITY OF FLORIDA (US) 1992-10-15 WO disclosed
US-5135926-A Treatment of prevention of cardiovascular disorders; treatment of glaucoma IVAX International GmbH (CH) 1992-08-04 US disclosed
WO-1992000988-A1 TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES BODOR NICHOLAS S (US) 1992-01-23 WO disclosed
US-5079366-A To derivatize pharmaceutical peptides for transport across the blood/brain barrier UNIVERSITY OF FLORIDA (US) 1992-01-07 US disclosed
EP-0174956-B1 SOFT $g(b)-ADRENERGIC BLOCKING AGENTS BODOR, Nicholas S. (US) 1990-08-16 EP disclosed
US-4888427-A DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX SYSTEM UNIVERSITY OF FLORIDA (US) 1989-12-19 US disclosed
US-4829086-A Soft β-adrenergic blocking agents IVAX International GmbH (CH) 1989-05-09 US disclosed
EP-0293071-A1 Redox amino acids and peptides containing them UNIVERSITY OF FLORIDA (US) 1988-11-30 EP disclosed
EP-0174956-A1 SOFT -g(b)-ADRENERGIC BLOCKING AGENTS. BODOR NICHOLAS S 1986-03-26 EP disclosed
WO-1985004168-A1 SOFT beta-ADRENERGIC BLOCKING AGENTS BODOR NICHOLAS S 1985-09-26 WO disclosed